M€ uller glia-derived progenitor cells (MGPCs) have the capability to regenerate neurons in the retinas of different vertebrate orders. The formation of MGPCs is regulated by a network of cellsignaling pathways. The purpose of this study was to investigate how BMP/Smad1/5/8-and TGFb/Smad2/3-signaling are coordinated to influence the formation of MGPCs in the chick model system. We find that pSmad1/5/8 is selectively up-regulated in the nuclei of M€ uller glia following treatment with BMP4, FGF2, or NMDA-induced damage, and this up-regulation is blocked by a dorsomorphin analogue DMH1. By comparison, Smad2/3 is found in the nuclei of M€ uller glia in untreated retinas, and becomes localized to the cytoplasm following NMDA-or FGF2-treatment.
. In the mammalian retina, M€ uller glia have a severely attenuated capacity to become MGPCs and this process requires neuronal cell death followed by growth factor stimulation, or overexpression of the pro-neural transcription factor ascl1 (Karl et al., 2008; Ooto et al., 2004; Ueki et al., 2015) . Similar to the retinas of fish and birds, MAPK-and Wnt/b-catenin-signaling have been implicated in driving MGPC formation in the rodent retina (reviewed by Hamon, Roger, Yang, & Perron, 2016) .
The purpose of this study was to investigate how BMP-and TGFbsignaling influence the formation of proliferating MGPCs in the chick model system. BMPs signal through coreceptors BMPR1 and ALK2/3/ 6, to phosphorylate Smad1/5/8, whereas TGFbs signal through TGFb-RII and ALK1/5 coreceptors to phosphorylate Smad2/3 (Brazil, Church, Surae, Godson, & Martin, 2015) . pSmad2/3 and pSmad1/5/8 both interact and compete with Smad4 to translocate to the nucleus to effect transcription (reviewed by Brazil et al., 2015) ; this provides a cell signaling-context wherein TGFb-and BMP-signaling may act in opposition to regulate the formation of MGPCs. The Smad transcription factors play a crucial role in neural stem cell function during development and in postnatal neurogenic niches (Aigner and Bogdahn, 2008; Bond, Bhalala, & Kessler, 2012) . It has been shown that BMP4-signaling through Smad1/5/8 promotes the proliferation of M€ uller glia in rodent retinal explants (Ueki and Reh, 2013) . The involvement of BMPsignaling in reprogramming M€ uller glia into proliferating progenitors in vivo remains unexplored. However, TGFb-signaling has been reported to suppress the proliferation of MGPCs in both zebrafish and rat retina (Close, Gumuscu, & Reh, 2005; Lenkowski et al., 2013) . Herein, we explore how TGFb-and BMP-signaling pathways are coordinated to influence the formation of MGPCs in the chick retina.
| M E T H O D S AN D M A T E R I A L S

| Animals
The use of animals in these experiments was in accordance with the guidelines established by the National Institutes of Health and the Ohio State University. Newly hatched wild type leghorn chickens (Gallus gallus domesticus) were obtained from Meyer Hatchery (Polk, Ohio).
Postnatal chicks were kept on a cycle of 12 hr light, 12 hr dark (lights on at 8:00 a.m.). Chicks were housed in a stainless steel brooder at about 258C and received water and Purina TM chick starter ad libitum.
| Intraocular injections
Chickens were anesthetized via inhalation of 2.5% isoflurane in oxygen and intraocular injections performed as described previously (Fischer, Seltner, Poon, & Stell, 1998) . For all experiments, the right eyes of chicks were injected with the "test" compound and the contra-lateral left eyes were injected with vehicle as a control. Compounds were injected in 20 lL sterile saline with 0.05 mg/ml bovine serum albumin added as a carrier. Compounds used in these studies included NMDA (38.5 or 154 lg/dose; Sigma-Aldrich), FGF2 (250 ng/dose; R&D systems), Smad3 inhibitor SIS3 (4 lg/dose; Sigma-Aldrich), BMPR-inhibitor DMH1 (4 lg/dose; Sigma-Aldrich), TGFb-receptor (Alk5) inhibitor SB4315432 (2 lg/dose; R&D Systems), recombinant human BMP4
(300 ng/dose; R&D Systems), recombinant human TGFb2 (300 ng/ dose; R&D Systems), and IGF (400 ng/dose; R&D Systems). Two lg of BrdU or EdU were injected to label proliferating cells. Injection paradigms are included in each figure.
| Reverse transcriptase PCR
Individual retinas were placed in 1 mL of Trizol Reagent (Invitrogen) and total RNA was isolated according to the Trizol protocol and resuspended in 50 lL RNAse free water. Genomic DNA was removed by using the DNA FREE kit provided by Ambion. cDNA was synthesized from mRNA by using Superscript TM III First Strand Synthesis System (Invitrogen) and oligodT primers according to the manufacturer's protocol. Control reactions were performed using all components with the exception of the reverse transcriptase to exclude the possibility that primers were amplifying genomic DNA.
PCR primers were designed by using the Primer-BLAST primer design tool at NCBI (http://www.ncbi.nlm.nih.gov/tools/primer-blast/).
Primer sequences and predicted product sizes are listed in Table 1. PCR reactions were performed by using standard protocols, Platinum TM Taq (Invitrogen) and an Eppendorf thermal cycler. PCR products were run on an agarose gel to verify the predicted product sizes.
| Fixation, sectioning, and immunocytochemistry
Tissues were fixed, sectioned, and immunolabeled as described previously (Fischer, Ritchey, Scott, & Wynne, 2008; Fischer et al., 2009b) .
Working dilutions and sources of antibodies used in this study are listed in Table 2 . None of the observed labeling was due to nonspecific labeling of secondary antibodies or autofluorescence because sections labeled with secondary antibodies alone were devoid of fluorescence. Secondary antibodies included donkey-anti-goat-Alexa488/ 568, goat-anti-rabbit-Alexa488/568/647, goat-anti-mouse-Alexa488/ 568/647, goat-anti-rat-Alexa488 (Life Technologies) diluted to 1:1000 in PBS plus 0.2% Triton X-100.
| Labeling for EdU or BrdU
For BrdU-labeling, immunolabeled sections were fixed in 2% paraformaldehyde for 10 min, washed for 5 min in PBS, washed for 8 min in 4N HCl, washed 33 times in PBS, and processed for immunolabeling with antibodies to BrdU.
For EdU-labeling, immunolabeled sections were fixed in 4% formaldehyde in PBS for 5 min at room temperature, washed for 5 min with PBS, permeabilized with 0.5% Triton X-100 in PBS for 1 min at room temperature, and washed twice for 5 min in PBS. Sections were incubated for 30 min at room temperature in 2M Tris, 50 mM CuSO 4 , 
| Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)
We used the TUNEL method to identify dying cells that contained fragmented DNA. We used an In Situ Cell Death Kit (TMR red; Roche Applied Science), as per the manufacturer's instructions.
| Photography, measurements, cell counts, and statistics
Photomicrographs were obtained using a Leica DM5000B microscope equipped with epifluorescence and Leica DC500 digital camera.
Confocal images were obtained using a Leica SP8 imaging system at the Hunt-Curtis Imaging Facility at The Ohio State University. Images were optimized for color, brightness and contrast, multiple channels overlaid and figures constructed by using Adobe Photoshop. Cell counts were performed on representative images. To avoid the possibility of region-specific differences within the retina, cell counts were consistently made from the same region of retina for each data set.
Similar to previous reports (Ghai, Zelinka, & Fischer, 2009; Stanke, Moose, El-Hodiri, & Fischer, 2010) , immunofluorescence was quantified by using ImagePro6.2 (Media Cybernetics, Bethesda, MD). Identical illumination, microscope, and camera settings were used to obtain images for quantification. Retinal areas were sampled from 5.4 MP digital images. These areas were randomly sampled over the inner nuclear layer (INL) where the nuclei of the bipolar and amacrine neurons were observed. Measurement for content in the nuclei of M€ uller glia/ sampled from six different retinas for each experimental condition. The mean area, intensity, and density sum was calculated for the pixels within threshold regions from 4 retinas for each experimental condition.
In Figure 1c -e, determination of the percentage of Smad2 in Sox21 nuclei in the INL was determined as follows, similar to previous descriptions (Gallina et al., 2016; Todd and Fischer, 2015) . do not migrate distally into the retina), and CD45 1 (Sox2/9 -) microglia (Fischer, Scott, Zelinka, & Sherwood, 2010; Zelinka, Scott, Volkov, & Fischer, 2012) . NIRG cells are a unique type of glial cell that has been described in the chick retina Rompani and Cepko, 2010) , and possibly the retinas of reptiles , that migrate into the retina from the optic nerve (Rompani and Cepko, 2010) . Sox2 1 nuclei in the INL were identified as M€ uller glia based on their large size and fusiform shape, which was distinctly different from the Sox2 1 nuclei of cholinergic amacrine cells, which are small and round ).
GraphPad Prism 6 was used for statistical analyses. Where significance of difference was determined between two treatment groups accounting for interindividual variability (means of treated-control values) we performed a two-tailed, paired t-test. Where significance of difference was determined between two treatment groups, we performed a two-tailed, unpaired t-test.
| R E S U L T S
3.1 | BMP-and TGFb-signaling are modulated following NMDA-damage
We first examined whether TGFb ligands were expressed in normal and NMDA-damaged chick retinas by using RT-PCR. We found tgfb1, tgfb2, and tgfb3 were present in normal retinas, with PCR products for tgfb2
suggesting highest levels of expression ( Figure 1a ). In NMDA-damaged retinas, tgfb ligands were detected with no obvious changes in levels of expression ( Figure 1a ). We next sought to characterize the TGFbassociated transcription factor, Smad2, in NMDA-damaged retinas. Intraocular injections of NMDA cause excitotoxic death of inner retinal neurons and the formation of proliferating MGPCs (Fischer and Reh, 2001 ).
Antibodies to pSmad2 (Cell Signaling Technologies; #3108) failed to produce convincing labeling in normal retinas or in response to intraocular injection of TGFb2 (data not shown). Thus, we relied upon patterns of labeling and subcellular distribution of Smad2 as readouts of signaling for TGFb/Smad2. We assumed that Smad2 that was localized within nuclei indicated cells with active TGFb-signaling; whereas Smad2 distributed throughout the cytoplasm indicated cells with the capacity to respond to TGFb-signaling but were inactive (Brazil et al., 2015) . In normal retina, we found most (60%) of the Smad2-immunofluorescence We next examined BMP ligand expression in normal and NMDAdamaged retinas by using RT-PCR. We observed that bmp2, bmp4, and bmp7 were present in normal and NMDA-damaged retinas at 4, 24, 48, and 72 hr after treatment ( Figure 1f ). There were no obvious differences in levels of PCR products in control and treated retinas. To determine whether BMP-signaling is active in normal or damaged retinas, retinal Significance of difference (***p < 0.001) was determined by using a two-tailed paired student's t-test. (f) RT-PCR was used to detect mRNA to bmp2, bmp4, bmp7, and gapdh in control and NMDA-treated retinas at 4, 24, 48, and 72 hr after treatment. (g-j) Retinas were labeled with antibodies to pSmad1/5/8 (green) and Top AP (red). Retinas were obtained for eyes injected with saline (vehicle) or BMP4 and harvested 4 hr later (h and i), or eyes were injected with 30% DMSO in saline (control) or DMH1 (treated) at P7, BMP4 (control) or BMP4 1 DMH1 (treated) at P8, and eyes harvested P9. (k, l) mean area (6SD) and mean density sum (6SD) of pSmad1/5/8-immunofluorescence in the INL of retinas treated with BMP4 versus BMP4 1 DMH1. Significance of difference (*p < 0.05,) was determined by using a Mann-Whitney U test. Arrows indicate the nuclei of MGPCs. The calibration bar (50 mm) in panel b applies to b alone, the bar in g applies to g alone, the bar in i applies to i alone, and the bar in j applies to d, e, and j. 
| Inhibition of BMPR1 attenuates MGPC formation in the damaged retina
In the chick retina, MGPCs are defined as M€ uller glia that: (i) dedifferentiate (i.e., down-regulated glutamine synthetase), (ii) up-regulate progenitor factors (such as Klf4, Six3, Pax6, Chx10, Egr1, nestin/transitin, ascl1a), and (iii) re-enter the cell cycle (up-regulate PCNA, pHisH3, and accumulate BrdU/EdU; reviewed by Gallina et al., 2014a,b and Bongini, 2010) . The M€ uller glia appear to uniformly activate cell signaling pathways such as MAPK, mTor, Wnt/b-catenin, Jak/Stat, and pSmad1/5/8 before acquisition of progenitor phenotype (Fischer et al., 2009b; Gallina et al., 2016; Zelinka et al., 2016) . Thus, we use proliferation as a defining characteristic of MGPCs.
To determine whether BMP-signaling is involved in the formation of MGPCs, we inhibited the BMPR1 receptor with DMH1 in NMDA- TGFb-ligand in the chick retina (see Figure 1a ) and is the most highly expressed TGFb-isoform in the retina and brain of rodents (Close et al., 2005; Constam, Schmid, Aguzzi, Schachner, & Fontana, 1994) . We found that TGFb2 significantly suppressed proliferating MGPCs in damaged retinas (Figure 3a,b) . TGFb2 did not affect the proliferation of NIRG cells but did inhibit microglia proliferation (Figure 3c,d) . 
| Inhibition of Smad3 enhances FGF2-mediated cell signaling in M€ uller glia and the proliferation of FGF2-induced MGPCs
We next investigated whether TGFb2 and signaling through Smad3 influences the formation of MGPCs in the absence of damage. We found inhibition of Smad3 with the small molecule inhibitor SIS3 had no effect upon M€ uller glia in normal retinas. A single intraocular injection of SIS3 failed to influence cell signaling in M€ uller glia; levels of pERK1/2, pS6, or pStat3 were unaffected (data not shown). We combined SIS3 with FGF2 to examine whether inhibition of Smad3 would facilitate FGF2-signaling. SIS3 co-applied with FGF2 for two consecutive days resulted in a significant increase in cFos in M€ uller glia, whereas levels of ps6 were unaffected (Figure 6a-d) . With four FIG URE 2 Inhibition of BMP-signaling suppresses the formation of proliferating MGPCs in damaged retinas. Eyes were injected with 500 nmol NMDA 1 vehicle (control) or NMDA 1 DMH1 (treated) at P7, vehicle 1 BrdU or DMH1 1 BrdU at P8 and P9, and retinas were harvested at P10. Retinal sections were labeled with antibodies to BrdU (green) and Sox9 (red). The box plots illustrate the mean, upper extreme, lower extreme, upper quartile and lower quartile. Arrows indicate the nuclei of MGPCs and the calibration bar in panel a represents 50 mm. Significance of difference (*p < 0.05) was determined by using a two-tailed paired student's t-test. Abbreviations: INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; ONL, outer nuclear layer [Color figure can be viewed at wileyonlinelibrary.com]
consecutive daily intraocular injections of FGF2, which are known to stimulate the formation of proliferating MGPCs (Fischer et al., 2014) , the subcellular distribution of Smad2 appeared to shift out of nuclei and into the cytoplasm of M€ uller glia (Figure 6e ), suggesting that signaling through TGFb/Smad2/3 was decreased in FGF2-treated retinas.
With three consecutive days of treatment, application of SIS3 with
TGFb2 inhibits the formation of proliferating MGPCs in NMDA-damaged retinas. Eyes were injected with 500 nmol NMDA 1 vehicle (control) or NMDA 1 TGFb2 (treated) at P6, vehicle 1 EdU or TGFb2 1 EdU at P7 and P8, and retinas harvested at P9. Sections of the retina were labeled for EdU (red) and antibodies to Sox9 (green; a), Klf4 (green) and Sox2 (red; e), Pax6 (green) and Sox9 (red; g), or Sox9 (green), and Egr1 (red; i). TGFb/Smad2-signaling is part of the network that inhibits the proliferation of MGPCs in FGF2-treated retinas. (a-d) Eyes were injected with FGF2 1 vehicle (control) or FGF2 1 SIS3 (treated) at P6 and P7, and retinas harvested at P8. (e) Eyes were injected with vehicle (control) or FGF2 (treated) at P6-P10 and retinas were harvested at P11. (f,g): Eyes were injected with FGF2 1 vehicle (control) or FGF2 1 SIS3 (treated) at P6, P7, and P8, EdU at P9, and retinas were harvested at P10. Sections of the retina were labeled with antibodies to cFos (green) and Sox2 (red) (a), ps6 (green) and Sox2 (red) (b), Smad2 (green) and Sox2 (red) (e), and EdU (red) and Sox2 (green) (f). The box plots illustrate the mean, upper extreme, lower extreme, upper quartile and lower quartile. The plots illustrates the control and treated levels (intensity sum) of cFos (b) and levels of pS6 (d). The plot in (g) represents the amount of proliferating M€ uller glia/MGPCs. Significance of difference (*p < 0.05, ***p < 0.001) was determined by using a two-tailed paired student's t-test. Arrows indicate the nuclei of MGPCs. The calibration bar (50 mm) in panel a applies to a, b, and f. Abbreviations: INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; ONL, outer nuclear layer [Color figure can be viewed at wileyonlinelibrary.com] FGF2 resulted in a significant increase in the number of proliferating
MGPCs compared with numbers seen in retinas treated with FGF2 alone (Figure 6f,g ).
In the majority of eyes (6 out of 8), the combination of TGFb2 and FGF2 resulted in significant retinal damage. We detected significant numbers of TUNEL-positive cells in the INL and GCL of retinas treated with TGFb2 and FGF2 (not shown). Thus, we were unable to determine whether TGFb2 influenced the formation of MGPCs in FGF2-treated eyes in the absence of damage. The causes underlying the retinal pathology remains uncertain, but may involve changes in vascular integrity given that blood was observed within the vitreous chamber of eyes treated with TGFb2 and FGF2 (not shown). Similarly, the combination of FGF2 and IGF1, but not either factor alone, results in cell death in the retina, but this results from angle closure and acute elevation of IOP (Ritchey, Zelinka, Tang, Liu, & Fischer, 2012 ).
| Proliferation of retinal progenitors in the circumferential marginal zone (CMZ)
To examine whether signaling through Smad3 influences the proliferation of progenitor cells other than MGPCs, we tested whether the proliferation of retinal progenitors in the CMZ was affected by the inhibitor SIS3. The eyes of post-hatch chicks are known to contain a CMZ at the far peripheral edge of the retina (Ghai, Stanke, & Fischer, 2008; Fischer, Dierks, & Reh, 2002; Fischer & Reh, 2000) . Intraocular injections of SIS3 alone had no effect upon the proliferation of CMZ progenitors (not shown). Thus, we examined if co-application of SIS3 with insulin-like growth factor 1 (IGF1), which is known to stimulate the proliferation of CMZ progenitors (Fischer & Reh, 2000) , influenced CMZ progenitors.
We found that application of SIS3 with IGF1 nearly doubled the number of newly generated cells added to the retina from proliferating CMZ progenitors (Figure 7a-c) . These findings suggest that CMZ progenitors, which proliferate in response to IGF1 may be suppressed by signaling through Smad3, but under normal conditions, signaling through Smad3 is not required to keep these progenitors quiescent.
Previous studies have shown that proliferating CMZ progenitors normally add new neurons to the peripheral edge of the retina (Fischer and Reh, 2000) . Further, treatment with IGF1/insulin not only stimulates the proliferation of CMZ progenitors, but includes progeny that differentiate as neurons (Fischer et al., 2002 ). Thus, we tested whether inhibition of TGFb-signaling, with SIS3, combined with IGF1 influenced the number of progeny that differentiate as neurons. We found that co-application of SIS3 and IGF1 had no significant effect upon the percentage of EdU-labeled cells that were positive for the neuronal markers HuD or Otx2 (data not shown). (Gallina et al., 2014a) . We found that Bmp2, -4, and -7 are present in normal and NMDA-damaged retinas.
Similarly, it has been reported that Bmp2, -4, and -7 are present in the embryonic chick retina (Belecky-Adams and Adler, 2001 ). In the developing chick eye, Noggin-soaked beads reduced proliferation in vivo and BMP4 increased proliferation in dissociated retinal progenitor cells (Trousse, Esteve, & Bovolenta, 2001 ). Over-expression of BMPR1 also induces proliferation during early stages of embryonic chick retinal regeneration (Haynes, Gutierrez, Aycinena, Tsonis, & Del Rio-Tsonis, 2007) . Collectively, these findings suggest that the proliferation of retinal progenitors is stimulated by BMP-signaling.
BMP-signaling may also promote reactive phenotypes in mature retinal glia. For example, astrocytes and the MIO-M1 M€ uller cell line upregulate genes associated with reactive gliosis in response to BMP7 treatment, which is consistent with findings that M€ uller glia normally express BMPR1 (Dharmarajan et al., 2014) . In contrast, treatment with BMP4 did not lead to any increase in genes associated with gliosis in MIO-M1 M€ uller glia (Dharmarajan et al., 2014) . Additionally, NMDA-treatment and light-induced damage stimulates Bmp2, 24, and 27 in the mouse retina (Ueki and Reh, 2012) . In human proliferative vitreoretinopathy, there is aberrant proliferation of M€ uller glia and this correlates with up-regulation of Bmp4 and Smad1 (Hollborn et al., 2005) . Taken together, these data suggest up-regulation of BMPsignaling may be a response common to different types of retinal injury across species and may promote proliferation of retinal glia.
We found that inhibition of BMPR1 with small molecule inhibitor DMH1 attenuated the proliferation of M€ uller glia in NMDA-damaged and FGF2-stimulated retinas. DMH1 is a BMPR1/ALK2 inhibitor that is based on the structure of Dorsomorphin, which is known to inhibit BMP4 mediated Smad1/5/8 phosphorylation (reviewed by Brazil et al., 2015) . Consistent with a previous report in the mouse retina (Ueki and Reh, 2012) , we observed pSmad1/5/8 activity predominantly in M€ uller glia cells after NMDA-induced retinal damage. In mouse retinal explants, Dorsomorphin and Noggin both suppressed EGF-induced proliferation of M€ uller glia (Ueki and Reh, 2013) . Similarly, Noggin suppresses FGF2-mediated retinal regeneration in the embryonic chick (Haynes et al., 2007) . In contrast with the embryonic chick retina ( (Kugler et al., 2015) . By comparison, in postnatal rat retina, TGFb-signaling potently suppresses the proliferation of progenitors during the later stages of retinal development (Close et al., 2005) , when there is a gradual acquisition of M€ uller glial phenotype coupled with a diminished ability of progenitors to proliferate (Nelson et al., 2011) . TGFb2 is expressed by inner retinal neurons and is the most highly expressed TGFb ligand, compared with TGFb1 and TGFb3, in the postnatal rat retina (Close et al., 2005) .
This implies that TGFb-ligand produced by maturing inner retinal neurons acts on late-stage retinal progenitors and M€ uller glia to promote the end of retinal histogenesis. Collectively, these findings suggest that during late stages of retinal development, TGFb-signaling may suppress proliferation and promote acquisition of glial character.
During neural development, BMP-signaling is known to influence the differentiation of neurons and glia, depending on the developmental context (Guillemot, 2007) . In cultures of early stage progenitors, BMP-signaling promotes neurogenesis, whereas in cultures of latestage progenitors, BMP-signaling increases astrocyte differentiation (Gross et al., 1996; Li, Cogswell, & LoTurco, 1998; Nakashima et al., 2001 ). In the adult subventricular zone, BMP-signaling influences the neurogenic niche to suppress neurogenesis from stem cells (Lim et al., 2000) . We found that modulation of BMP/Smad1/5/8-signaling had no effect upon the number of progeny derived from MGPCs that differentiated as neurons. Similarly, in the developing chick embryo, data suggests that BMP-signaling does not influence the differentiation of retinal neurons (Huang, Liu, Oltean, & Beebe, 2015; Muller, Rohrer, & Vogel-Hopker, 2007; Steinfeld et al., 2013) . Thus, the retina may be different from other regions of the CNS in that BMP/Smad1/5/8-signaling does not influence specification of neuronal and glial cells types.
| C O NC LU S I O N S
We conclude that the formation of proliferating MGPCs in damaged or 
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